HomeAboutRankingsData Sources
© 2026 GeneE
🧬
GeneE
10 sources retrieved · Most recent: April 2026 · Index updated 15 days ago
ⓘGeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
TENT5C
terminal nucleotidyltransferase 5C
Chromosome 1 · 1p12
NCBI Gene: 54855Ensembl: ENSG00000183508.6HGNC: HGNC:24712UniProt: Q5VWP2
32PubMed Papers
20Diseases
0Drugs
0Pathogenic Variants
DATA QUALITY
✓ Experimental GO Evidence✓ Swiss-Prot Reviewed
protein bindingpoly(A) RNA polymerase activitynegative regulation of cell differentiationmRNA stabilizationmultiple myelomatype 2 diabetes mellitusdiabetes mellitusThromboembolism
✦AI Summary

TENT5C (terminal nucleotidyltransferase 5C) is a noncanonical poly(A) polymerase that functions as a tumor suppressor and secretory pathway regulator 1. As a member of the TENT5 family, TENT5C selectively stabilizes mRNAs encoding endoplasmic reticulum-imported proteins, thereby promoting expression of secretory cargo and proteins involved in protein folding and trafficking 1. TENT5C likely functions together with its paralog TENT5A in regulating cytoplasmic polyadenylation of secreted proteins during bone formation 2. Mechanistically, TENT5C acts as a corepressor in ligand-bound glucocorticoid receptor and estrogen receptor α complexes, with its third LXXLL motif directly interacting with estrogen receptor α 3. Additionally, TENT5C localizes to centrioles and inhibits Polo-like kinase 4 activity independent of its nucleotidyl transferase function, thereby suppressing centriole duplication and cancer cell invasion 4. Clinically, TENT5C is frequently mutated or deleted in multiple myeloma patients, where loss-of-function mutations confer selective advantage to malignant plasma cells by reducing secretory capacity 5. Loss of TENT5C is also documented in advanced colorectal cancer 4. Conversely, TENT5C expression sensitizes myeloma cells to sphingosine kinase 1 inhibition, suggesting therapeutic potential 6. In neuroinflammation, TENT5C downregulation mediates neuroprotective anti-inflammatory effects of mild hypothermia 7.

Sources cited
1
TENT5C (terminal nucleotidyltransferase 5C) is a noncanonical poly(A) polymerase that functions as a tumor suppressor and secretory pathway regulator .
PMID: 40407157
2
TENT5C likely functions together with its paralog TENT5A in regulating cytoplasmic polyadenylation of secreted proteins during bone formation .
PMID: 33882302
3
Mechanistically, TENT5C acts as a corepressor in ligand-bound glucocorticoid receptor and estrogen receptor α complexes, with its third LXXLL motif directly interacting with estrogen receptor α .
PMID: 40421654
4
Additionally, TENT5C localizes to centrioles and inhibits Polo-like kinase 4 activity independent of its nucleotidyl transferase function, thereby suppressing centriole duplication and cancer cell invasion .
PMID: 32807875
5
Clinically, TENT5C is frequently mutated or deleted in multiple myeloma patients, where loss-of-function mutations confer selective advantage to malignant plasma cells by reducing secretory capacity .
PMID: 34117720
6
Conversely, TENT5C expression sensitizes myeloma cells to sphingosine kinase 1 inhibition, suggesting therapeutic potential .
PMID: 40427516
7
In neuroinflammation, TENT5C downregulation mediates neuroprotective anti-inflammatory effects of mild hypothermia .
PMID: 38484570
Disease Associationsⓘ20
multiple myelomaOpen Targets
0.54Moderate
type 2 diabetes mellitusOpen Targets
0.51Moderate
diabetes mellitusOpen Targets
0.48Moderate
ThromboembolismOpen Targets
0.42Moderate
nephrolithiasisOpen Targets
0.41Moderate
skin squamous cell carcinomaOpen Targets
0.37Weak
bile duct carcinomaOpen Targets
0.37Weak
cecum adenocarcinomaOpen Targets
0.37Weak
cutaneous melanomaOpen Targets
0.37Weak
Endometrial Endometrioid AdenocarcinomaOpen Targets
0.37Weak
lung carcinomaOpen Targets
0.37Weak
migraine disorderOpen Targets
0.36Weak
premature birthOpen Targets
0.36Weak
diabetic retinopathyOpen Targets
0.34Weak
diabetic eye diseaseOpen Targets
0.33Weak
cataractOpen Targets
0.33Weak
hemorrhagic diseaseOpen Targets
0.33Weak
thrombocytopenia 4Open Targets
0.33Weak
diabetic neuropathyOpen Targets
0.33Weak
gestational diabetesOpen Targets
0.32Weak
Pathogenic Variants
No pathogenic variants reported on ClinVar for this gene.
View on ClinVar ↗
Related Genes
CEP192Protein interaction100%PLK4Protein interaction92%DIS3Protein interaction79%TENT5DShared pathway50%TAF15Shared pathway50%LARP1BShared pathway33%
Tissue Expression6 tissues
Bone Marrow
100%
Lung
11%
Heart
11%
Liver
8%
Ovary
5%
Brain
1%
Gene Interaction Network
Click a node to explore
TENT5CCEP192PLK4DIS3TENT5DTAF15LARP1B
PROTEIN STRUCTURE
Preparing viewer…
PDB6W36 · 2.85 Å · X-ray
View on RCSB ↗
Constraintⓘ
LOEUFⓘ
0.45Moderately Constrained
pLIⓘ
0.99Intolerant
Observed/Expected LoF0.21 [0.11–0.45]
RankingsWhere TENT5C stands among ~20K protein-coding genes
  • #11,628of 20,598
    Most Researched32
  • #2,493of 17,882
    Most Constrained (LOEUF)0.45 · top quartile
Genes detectedTENT5C
Sources retrieved10 papers
Response time—
📄 Sources
10▼
1
Cytoplasmic polyadenylation by TENT5A is required for proper bone formation.
PMID: 33882302
Cell Rep · 2021
1.00
2
The Immunity-malignancy equilibrium in multiple myeloma: lessons from oncogenic events in plasma cells.
PMID: 34117720
FEBS J · 2022
0.90
3
TENT5C functions as a corepressor in the ligand-bound glucocorticoid receptor and estrogen receptor α complexes.
PMID: 40421654
FEBS J · 2025
0.80
4
Mild hypothermia reduces lipopolysaccharide-induced microglial activation via down-regulation of Tent5c.
PMID: 38484570
Biochem Biophys Res Commun · 2024
0.70
5
TENT5/FAM46: An Enigmatic Family of Secretory Tuners.
PMID: 40407157
Traffic · 2025
0.60